Samoa has become the first country to implement the new triple drug regimen recommended by WHO for the treatment of lymphatic filariasis (LF), a disabling and disfiguring neglected tropical disease.

Annual mass treatment of the entire eligible population of Samoa began on 14 August and is expected to be completed by 26 August. “Together with the Ministry of Health Samoa, we have ensured that dispositions are in place to enable the mass treatment of an estimated 180 000 people as part of their renewed national plan to eliminate lymphatic filariasis as a public health problem” said Dr Rasul Baghirov, WHO Representative in Samoa. “With the support of partners and donated medicines from the pharmaceutical industry, the Government of Samoa has been demonstrating its strong commitment to ensure that filariasis is finally eliminated from Samoa".

Health teams in all communities started mass treatment of children in primary schools and made house-to-house visits to provide the treatment to all eligible individuals in the community in Savaii, the largest island of Samoa. Health workers and volunteers ensured that people took the medication under their direct supervision… (WHO, August 25.8.18)